Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
81 studies found for:    immune thrombocytopenia OR immune thrombocytopenic purpura OR idiopathic thrombocytopenic purpura | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
immune thrombocytopenia OR immune thrombocytopenic purpura OR idiopathic thrombocytopenic purpura | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Development of Countermeasures Against Adverse Metabolic Effects of Shift Work
Condition: Circadian Dysregulation
Intervention: Behavioral: Meal schedule
2 Recruiting Effect of Dietary Habits on Metabolic Health
Conditions: Overweight;   Obesity;   Prediabetes;   Meals
Intervention: Behavioral: Meal schedule
3 Recruiting Protein, Amino Acids & Insulin & Glucagon Secretion in Humans
Conditions: Type 2 Diabetes;   Metabolic Syndrome
Intervention: Other: water, glucose with or without amino acid
4 Recruiting Objective Assessment of Behavioral Associations of Patients With Dementia
Conditions: Dementia;   Psychomotor Agitation
Intervention:
5 Recruiting Health-related Quality of Life in Rare Kidney Stone
Conditions: Primary Hyperoxaluria;   Cystinuria;   Adenine Phosphoribosyl Transferase Deficiency;   Dent Disease
Intervention: Other: Health-related Quality of Life in Rare Kidney Stone Wuestionnaire
6 Recruiting Chronic Pain Risk Associated With Menstrual Period Pain
Conditions: Cystitis, Interstitial;   Dysmenorrhea;   Migraine Disorders;   Pelvic Pain;   Endometriosis;   Visceral Pain;   Chronic Pain
Intervention: Drug: microgestin 1/20
7 Recruiting A Salivary miRNA Diagnostic Test for Autism
Conditions: Autism Spectrum Disorder;   Developmental Delay
Interventions: Other: Salivary collection;   Other: Vineland Adaptive Behavior Scale-II Assessment;   Other: Medical history questionaire;   Other: Autism Diagnostic Observation Schedule -2nd edition (ADOS-2)
8 Recruiting Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens
Condition: Normal Neutrophil Function
Intervention:
9 Not yet recruiting Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability
Conditions: Colon Adenocarcinoma;   DNA Repair Disorder;   Lynch Syndrome;   Microsatellite Instability;   Stage IIIA Colon Cancer;   Stage IIIB Colon Cancer;   Stage IIIC Colon Cancer
Interventions: Drug: Atezolizumab;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin;   Other: Quality-of-Life Assessment
10 Recruiting Diuretic Comparison Project
Condition: Hypertension
Interventions: Drug: Hydrochlorothiazide (HCTZ);   Drug: Chlorthalidone
11 Recruiting Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Conditions: Adult Solid Neoplasm;   Metastatic Melanoma;   Metastatic Renal Cell Cancer;   Recurrent Colorectal Carcinoma;   Recurrent Melanoma;   Recurrent Ovarian Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Ovarian Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Biological: Ziv-Aflibercept
12 Not yet recruiting ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Conditions: Oral Cavity Neoplasm;   Oropharyngeal Neoplasm;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet;   Other: Pharmacological Study;   Other: Placebo
13 Recruiting Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma of the Skin;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Sargramostim
14 Recruiting Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck
Condition: Head And Neck Cancer
Interventions: Radiation: Intensity-Modulated X-Ray Therapy (IMRT);   Radiation: Intensity-Modulated Proton Beam Therapy (IMPT);   Procedure: Modified barium swallow (MBS);   Behavioral: Questionnaires
15 Recruiting Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Biological: Bevacizumab;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis
16 Recruiting Gastroparesis Registry 2
Conditions: Gastroparesis;   Diabetic Gastroparesis;   Idiopathic Gastroparesis
Intervention:
17 Recruiting Safety and Durability of Sirolimus for Treatment of LAM
Condition: Lymphangioleiomyomatosis
Interventions: Drug: Sirolimus;   Drug: Everolimus
18 Recruiting Improving Balance in TBI Using Virtual Reality
Condition: Traumatic Brain Injury
Interventions: Other: Standard of Care Balance Intervention;   Other: Mystic Isle Balance Intervention;   Other: Mystic Isle Balance Intervention with Dual Task
19 Recruiting Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: decitabine
20 Recruiting Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sunitinib malate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.